In the rapidly evolving world of aesthetic medicine, the quest for a more youthful appearance has propelled injectable dermal fillers to the forefront of non-surgical rejuvenation. With over 5.3 million procedures performed in 2024 alone, hyaluronic acid (HA) fillers have become the gold standard for restoring lost facial volume and smoothing deep lines. However, until recently, the clinical understanding of exactly how these fillers behave over time—and how that behavior correlates with patient satisfaction—has relied largely on qualitative observations.
A groundbreaking study published in the October issue of Plastic and Reconstructive Surgery®, the official journal of the American Society of Plastic Surgeons (ASPS), has changed that landscape. By utilizing high-precision 3D digital scanning technology alongside standardized patient-reported outcomes, researchers have provided the most granular look yet at the lifecycle of facial fillers.
Main Facts: The Intersection of Precision and Perception
The research, led by Dr. Ivona Percec, MD, PhD, an ASPS Member Surgeon at the University of Pennsylvania, sought to bridge the gap between subjective patient experience and objective, measurable volumetric changes. The study followed 101 women, aged 40 to 65, as they underwent various HA filler treatments across eight distinct facial zones.
The core of the study’s innovation lies in its dual-methodology approach. By combining the Vectra M3 3D imaging system—which captures sub-millimeter changes in tissue volume—with the validated FACE-Q questionnaire, the team was able to map exactly how much filler remains in the skin versus how much is absorbed, and how those physical changes translate to the patient’s psychological and social well-being.
"Our study combines objective measurements of volumetric effects with patient satisfaction and other subjective outcomes to provide a deeper understanding of the immediate and long-term course of improvement after treatment with HA fillers," explains Dr. Percec.
Chronology of Volumetric Change: From Injection to 12 Weeks
Understanding the timeline of a filler injection is critical for both the practitioner and the patient. The study provides a clear, data-backed timeline of how HA fillers settle into the tissue following the initial procedure.
The Immediate Aftermath: The "Swelling" Phase
Immediately following an injection, 3D scans revealed a significant increase in facial volume—ranging from 56% to 125%. The researchers noted that these initial numbers are inflated by the body’s natural response to trauma: localized swelling and inflammation. At this stage, the "Tissue Displacement Factor" (TDF) is at its peak, often leading to a temporary appearance of over-correction.
The Two-Week Stabilization
By the two-week mark, the initial inflammatory response has largely subsided. The study identifies this timeframe as the critical "Effective Volume" (EV) window. At two weeks, the filler has integrated into the tissue, and the results provide a much more accurate representation of the final, long-term outcome. During this phase, the mid-face and lower-face fillers retained approximately 90% of their initial volume, while lip treatments showed roughly 70% retention.
The 12-Week Maintenance
At the three-month (12-week) follow-up, the data began to reflect the unique biological behavior of different facial regions. The "whole-face" volume maintenance settled at roughly 66%. However, this varied significantly by area:
- Midface and Cheeks: These areas showed the highest stability, with 79% volume maintenance.
- Perioral Region (Marionette lines): These areas maintained 63% of the initial volume.
- Lips: The lips showed the most significant decrease, maintaining only 37% of the initial volume.
Supporting Data: Why Facial Regions Differ
The variability in volume retention is one of the study’s most significant findings. The researchers attribute the rapid decline in lip volume to two primary factors: anatomical mobility and the rheological properties of the filler itself.
The lips are areas of "greater animation." Constant movement—speaking, eating, and facial expressions—exerts mechanical stress on the filler, which can accelerate the natural metabolic breakdown of the hyaluronic acid. Furthermore, the products specifically designed for the lips are often formulated with smaller particles, which are inherently more susceptible to natural degradation than the robust, larger-particle fillers used for structural support in the cheeks.
The study also highlights that "patient-specific variables" play a major role in the longevity of the results. Age, a history of smoking, and body mass index (BMI) were all found to influence how quickly the body metabolizes the HA. These factors suggest that a "one-size-fits-all" approach to filler volume is suboptimal and that clinicians must tailor their injection techniques to the individual’s metabolic profile.
Official Responses and Clinical Implications
For plastic surgeons and dermatologists, these data provide a vital tool for patient counseling. One of the most common complaints in aesthetic medicine is the "disappearing" filler. By sharing this data with patients, surgeons can set realistic expectations regarding the difference between the "immediate" look—which includes swelling—and the "final" look, which emerges after the two-week integration period.
"These and other patient-specific variables contribute significantly to outcomes of HA gel injections, requiring individual assessment," Dr. Percec noted.
The integration of the FACE-Q questionnaire provided the necessary human context to the cold, hard numbers of the 3D scans. Even as physical volume decreased from the immediate post-injection peak, patient satisfaction remained consistently high at the 12-week mark. This indicates that the "Effective Volume" achieved by the two-week mark is not only aesthetically pleasing but also contributes to long-term gains in psychological and social functioning. Patients reported feeling more confident in social settings and more satisfied with their overall facial appearance, reinforcing the idea that volume restoration is about more than just filling lines; it is about restoring a sense of self.
The Future of Aesthetic Counseling
The researchers argue that the objective data on volumetric effects, specifically the TDF and EV, should become standard components of pre-treatment counseling. By using these metrics, practitioners can guide patients through the stages of their recovery, ensuring they understand that the slight loss of volume following the initial week is a natural part of the product’s integration, not a sign of treatment failure.
This study serves as a definitive resource for evidence-based aesthetic practice. By mapping the lifecycle of HA fillers, Dr. Percec and her team have provided a blueprint for how practitioners can optimize clinical outcomes, minimize patient anxiety, and ensure that the pursuit of a youthful appearance is grounded in scientific reality.
As the industry continues to grow, the reliance on high-fidelity imaging and patient-reported outcomes will likely become the standard for all cosmetic procedures. The findings in Plastic and Reconstructive Surgery remind us that while the art of the injection is essential, it is the science of the long-term result that ultimately defines the success of the procedure.
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in professional information, software solutions, and services for the healthcare, tax and accounting, financial, and corporate compliance sectors. With operations in over 40 countries and serving customers in over 180, the company remains dedicated to providing expert solutions that combine deep domain knowledge with specialized technology. Headquartered in Alphen aan den Rijn, the Netherlands, Wolters Kluwer continues to support the medical community through the publication of high-impact research in journals such as Plastic and Reconstructive Surgery. For more information, visit www.wolterskluwer.com.
Article Reference: "A Large Prospective Volumetric and Patient-Reported Outcome Analysis of Hyaluronic Acid Facial Fillers" (doi: 10.1097/PRS.0000000000012135). Published October 2025.
About the Author
